Metraipolis › archive › dc_6437da985b86
SUVmax-IPI as a New Prognostic Index in Metastatic Non-Small Cell Lung Cancer Patients Receiving Nivolumab — Europe PMC PMID:41149486
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41149486
- DOI
- 10.3390/curroncol32100566
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T10:52:40.150Z
- SHA-256 of the archived text
fe88b83e1d6c2969fde6b14d50ac4d3d8904e3283a91e4be9bda304a964b6e42- Stable URL of this page
https://metraipolis.com/documento/dc_6437da985b86
How to cite
SUVmax-IPI as a New Prognostic Index in Metastatic Non-Small Cell Lung Cancer Patients Receiving Nivolumab — Europe PMC PMID:41149486 — Europe PMC (en), https://europepmc.org/article/MED/41149486 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6437da985b86 (Metraipolis archive dc_6437da985b86, sha256 fe88b83e1d6c2969fde6b14d50ac4d3d8904e3283a91e4be9bda304a964b6e42)
BibTeX
@misc{dc6437da985b86,
title = {SUVmax-IPI as a New Prognostic Index in Metastatic Non-Small Cell Lung Cancer Patients Receiving Nivolumab — Europe PMC PMID:41149486},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41149486},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6437da985b86; sha256 fe88b83e1d6c2969fde6b14d50ac4d3d8904e3283a91e4be9bda304a964b6e42},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41149486. Agents can read the archived copy with the MCP tool read_document.